Navigation Links
Wound Management Technologies, Inc. Announces Evidence Based Study
Date:6/3/2008

rom new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events. Compensation Disclaimer: Capital Pros Network CPN has been compensated the equivalent of $50,000 from MBSB.OB. Certain oral statements made by management from time to time and certain statements contained in press releases and periodic reports issued by Capital Pros Network or MBSB.OB (the "Company"), as well as those contained herein, that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934 and, because such statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements.

(1) ECPN January 2007


'/>"/>
SOURCE Wound Management Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial
2. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
3. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
4. Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Trial
5. Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Bodys Own Naturally Occurring Stem Cells
6. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
7. Studies Point to Benefits of Personalized Chemotherapy Dose Management in Colorectal Cancer
8. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
9. Micromet Announces Changes in Management Team
10. Lilly Receives NCQA Design Certification for Depression Care Management Program
11. New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014  DNAtrix, Inc., experts ... first patient was treated with the company,s lead ... interferon in a randomized, multicenter, open-label Phase Ib ... "DNAtrix, in collaboration with leading neurosurgeons and neuro-oncologists ... initiation of our randomized Phase Ib study of ...
(Date:9/16/2014)... NEW YORK , Sept. 16, 2014  Relmada ... therapies for the treatment of chronic pain, announced today ... Sloan Kettering Cancer Center (MSKCC) in a series of ... ER, a new tamper-resistant, extended release form of levorphanol. ... investigator for these studies. Dr. Pasternak ...
(Date:9/16/2014)... 16, 2014  Eli Lilly and Company (NYSE: ... an agreement to co-develop and commercialize AZD3293, an ... in development as a potential treatment for Alzheimer,s ... is characterized by the accumulation of amyloid plaque ... with the development of beta-amyloid. Inhibiting BACE is ...
Breaking Medicine Technology:DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 3Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 2Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 3Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 4
... for inherited conditions, ROCHESTER, Minn., Sept. 11 ... can be used to regenerate,heart tissue to treat ... was expedited by the editors of Stem Cells ... journal,s Web site at, http://stemcells.alphamedpress.org/ ., The ...
... PURCHASE, N.Y., Sept. 11 Nutrition 21, ... marketer of nutritional supplements under,the Iceland Health ... manage blood sugar levels, improve cardiovascular health, ... today that study results,released by the National ...
Cached Medicine Technology:Stem Cell Regeneration Repairs Congenital Heart Defect 2Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate 2Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate 3Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate 4
(Date:9/16/2014)... (PRWEB) September 16, 2014 SAMHSA, the federal ... mission a reduction of the impact of substance abuse and ... on the SAMHSA website in September is National Recovery Month, ... honor the gains made by those individuals in recovery. ... to addiction treatment in an effort to help those with ...
(Date:9/16/2014)... REDWOOD CITY, CALIF. (PRWEB) September 16, 2014 ... contact center and customer service solutions, announced today ... Group Excellence in Learning Award for the creation ... for independent contractor agents. Brandon Hall Group honors ... strategies, modalities, processes, systems and tools that have ...
(Date:9/16/2014)... Former Major League Baseball relief pitcher ... heart transplantation surgery at Allegheny General Hospital (AGH) on ... of his 16-year baseball career with the Pittsburgh Pirates ... Root Sports Pittsburgh, was discharged home on Friday, September ... surgical director of AGH’s heart transplant program. , “Mr. ...
(Date:9/16/2014)... inoperable, early-stage lung cancer who receive stereotactic body ... of 40 percent, according to research presented today ... 56th Annual Meeting. Such a positive survival rate ... in poor tumor control for patients with inoperable ... RTOG 0236, originally published in 2010 , and ...
(Date:9/16/2014)... to be on the heavy side. Researchers at the ... seven in every ten obese adults underestimate how much ... much less often. Mothers of overweight or obese children ... misjudge their obese mothers, size, says lead author Tracy ... in the Journal of General Internal Medicine , ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Booklet Offers Tips During Recovery Month 2Health News:Narconon Arrowhead Booklet Offers Tips During Recovery Month 3Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 2Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 3Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 4Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 2Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 3Health News:Long-term results of RTOG 0236 confirm good primary tumor control, positive 5-year survival rates 2Health News:Long-term results of RTOG 0236 confirm good primary tumor control, positive 5-year survival rates 3Health News:Poor body size judgement can lead to increased tolerance of obesity 2
... Your Medicines and You, Event Provides Free Pharmacist Reviews ... Mistakes, CHICAGO, Oct. 31 The following is ... one of the leading causes of death for,individuals over ... are teaming,up this Thursday to help people better manage ...
... Oct. 31 Varian, Inc.,(Nasdaq: VARI ) ... TOP-DNA and TOP-RNA, for the purification of,synthetic oligonucleotides ... used by life science researchers to,study the functions ... to work,properly, salts and incomplete products need to ...
... 11:01 AM October 31, 2007, WASHINGTON, ... of AARP told lawmakers what American families,already know ... our country is,the skyrocketing costs of health care., ... CEO Bill Novelli testified at a Senate Budget ...
... Another Scientific Review ... ... DENVER, Oct. 31 "The WCRF/AICR recommendations about,red meat and cancer are unsubstantiated ... red meat in a healthy,diet that far outweigh anything we,ve seen today. "There ...
... Open-Bore, Design to Bring High-Resolution MR Imaging to More Patients ... ... MALVERN, Pa., Oct. 31 Combining 3 Tesla strength and,sensitivity with a ... a 3 Tesla (T) MRI system with a 70 cm open bore ...
... to ways to treat injury, stroke and even Alzheimer,s, experts ... new U.S. study involving mice suggests the brain,s own stem ... injury. , These neural stem cells work by protecting existing ... team at the University of California, Irvine, were able to ...
Cached Medicine News:Health News:Varian, Inc. Offers New Products for the Rapid Purification of Synthetic Oligonucleotides. 2Health News:AARP CEO Bill Novelli Tells Lawmakers: Controlling Health Care Costs Key to Budget Reform 2Health News:NCBA Statement on 2007 WCRF/AICR Second Expert Report on Food, Nutrition and Physical Activity and the Prevention of Cancer: 2Health News:3 Tesla + 70 cm + Tim = The Most Exciting Equation in MRI 2Health News:3 Tesla + 70 cm + Tim = The Most Exciting Equation in MRI 3Health News:3 Tesla + 70 cm + Tim = The Most Exciting Equation in MRI 4Health News:Stem Cells Restore Memory in Mice 2Health News:Stem Cells Restore Memory in Mice 3
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
... German Craftsmanship have produced ... in the world. Ocutek® ... to you! Only holders ... certificate, which requires and ...
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
Medicine Products: